{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:01:28Z","timestamp":1788314488514,"version":"build-2803163510"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Respir Care"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Inhaled nitric oxide (INO) reduces extracorporeal membrane oxygenation (ECMO) use in term and near-term neonates with persistent pulmonary hypertension of the newborn; however, its overutilization is increasing. We hypothesized that implementing a shared baseline protocol would safely improve evidence-based INO use in a Level IV neonatal ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Through several plan-do-study-act cycles, a shared baseline protocol for initiation and weaning of INO was developed and implemented starting in August 2014. Based on user feedback, the shared baseline protocol was amended and re-evaluated at regular intervals. Significant changes for process and outcome measures related to utilization of INO were detected using statistical process control, bivariate analyses using\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      test or nonparametric Wilcoxon rank-sum test as appropriate, and chi-square and Fisher exact testing as appropriate. Comparisons between the pre-plan-do-study-act group (January 2012 to July 2014) and post-plan-do-study-act group (August 2014 to October 2015) were made.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      One hundred sixteen INO courses in 95 subjects were administered during the pre-plan-do-study-act period, and 44 episodes were initiated in 39 subjects during the post-plan-do-study-act period. Process control charts demonstrate significant reductions in the percentage of INO doses &gt; 20 ppm and the percentage of prolonged (&gt;4-d) INO courses. Prolonged INO courses decreased from 67.9 to 40% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .032), whereas the median duration of INO per course decreased from 8 to 4 d (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). The percentage of INO courses that exceeded the dose of 20 ppm decreased from 18.1 to 2.3% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .009). Very delayed INO weaning (weaning at F\n                      <jats:sub>\n                        IO\n                        <jats:sub>2<\/jats:sub>\n                      <\/jats:sub>\n                      \u2264 0.40) decreased from 41.9 to 21.2% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .038). There were no differences in the percentage of INO courses administered to non-sedated subjects or the percentage of INO courses administered to preterm infants. There was no difference for death or ECMO between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Implementation of a shared baseline protocol to encourage appropriate INO initiation and weaning safely decreased INO exposures. Focused efforts on reducing unapproved INO use in preterm infants are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4187\/respcare.05619","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T21:10:31Z","timestamp":1507065031000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["A Quality Improvement Project to Improve Evidence-Based Inhaled Nitric Oxide Use"],"prefix":"10.1177","volume":"63","author":[{"given":"Colleen A","family":"Hughes Driscoll","sequence":"first","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Miles","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"El-Metwally","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland."},{"name":"Pediatrics Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134595.80170.62"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702273360901"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002173420704"},{"key":"e_1_3_2_5_2","unstructured":"United States Food and Drug Administration. Drugs@FDA; FDA approved drug products. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process. Accessed January 17 2017."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2644"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2010.37"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-3290"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2016.49"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.105"},{"issue":"4","key":"e_1_3_2_11_2","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term","author":"Finer NN","year":"2006","unstructured":"Finer NN, , Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev, 2006;(4):CD000399.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.2.344"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/17.2.95"},{"issue":"5","key":"e_1_3_2_14_2","first-page":"1","article-title":"NIH Consensus Development Conference statement on inhaled nitric oxide therapy for premature infants","volume":"27","author":"Cole FS","year":"2010","unstructured":"Cole FS, , Alleyne C, , Barks JD, , Boyle RJ, , Carroll JL, , Dokken D, et al. NIH Consensus Development Conference statement on inhaled nitric oxide therapy for premature infants. NIH Consens State Sci Statements, 2010; 27(5):1\u201334.","journal-title":"NIH Consens State Sci Statements"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-1809"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1571329"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-4011"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0737"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4847.96739"},{"issue":"1","key":"e_1_3_2_20_2","first-page":"e040124","article-title":"Weaning of inhaled nitric oxide: is there a best strategy?","volume":"4","author":"Ware AM","year":"2015","unstructured":"Ware AM, , Golombek SG. Weaning of inhaled nitric oxide: is there a best strategy?. J Pediatr Neonatal Individ Med, 2015; 4(1):e040124. doi: 10.7363\/040124.","journal-title":"J Pediatr Neonatal Individ Med"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019514-200109030-00003"},{"key":"e_1_3_2_22_2","unstructured":"Agency for Healthcare Research and Quality. The six domains of health care quality. 2016. http:\/\/www.ahrq.gov\/professionals\/quality-patient-safety\/talkingquality\/create\/sixdomains.html#_ftn2. Accessed June 8 2016."},{"key":"e_1_3_2_23_2","unstructured":"Institute of Medicine. Performance measurement: accelerating improvement. Washington DC: National Academy Press; 2005."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.4025"},{"key":"e_1_3_2_25_2","unstructured":"Gamble M. 8 types of waste in healthcare. Becker's Hospital Review. September 10 2013. http:\/\/www.beckershospitalreview.com\/hospital-management-administration\/8-types-of-waste-in-healthcare.html. Accessed August 26 2017."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5444"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390200025005"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03308"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.0358"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2016-0003"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2013.75"}],"container-title":["Respiratory Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4187\/respcare.05619","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.05619","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.05619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:08:57Z","timestamp":1775473737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4187\/respcare.05619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.4187\/respcare.05619"],"URL":"https:\/\/doi.org\/10.4187\/respcare.05619","relation":{},"ISSN":["0020-1324"],"issn-type":[{"value":"0020-1324","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}